Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data

被引:1
|
作者
Izadi, Zara [1 ]
Gianfrancesco, Milena [1 ]
Anastasiou, Christine [1 ]
Schmajuk, Gabriela [1 ,2 ]
Yazdany, Jinoos [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] San Francisco VA Med Ctr, San Francisco, CA USA
来源
LUPUS SCIENCE & MEDICINE | 2024年 / 11卷 / 01期
关键词
Lupus Nephritis; Lupus Erythematosus; Systemic; Epidemiology; Antibodies; Antirheumatic Agents; ERYTHEMATOSUS; IDENTIFICATION; CLASSIFICATION;
D O I
10.1136/lupus-2024-001170
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Accurate identification of lupus nephritis (LN) cases is essential for patient management, research and public health initiatives. However, LN diagnosis codes in electronic health records (EHRs) are underused, hindering efficient identification. We investigated the current performance of International Classification of Diseases (ICD) codes, 9th and 10th editions (ICD9/10), for identifying prevalent LN, and developed scoring systems to increase identification of LN that are adaptable to settings with and without LN ICD codes.Methods Training and test sets derived from EHR data from a large health system. An external set comprised data from the EHR of a second large health system. Adults with ICD9/10 codes for SLE were included. LN cases were ascertained through manual chart reviews conducted by rheumatologists. Two definitions of LN were used: strict (definite LN) and inclusive (definite, potential or diagnostic uncertainty). Gradient boosting models including structured EHR fields were used for predictor selection. Two logistic regression-based scoring systems were developed ('LN-Code' included LN ICD codes and 'LN-No Code' did not), calibrated and validated using standard performance metrics.Results A total of 4152 patients from University of California San Francisco Medical Center and 370 patients from Zuckerberg San Francisco General Hospital and Trauma Center met the eligibility criteria. Mean age was 50 years, 87% were female. LN diagnosis codes demonstrated low sensitivity (43-73%) but high specificity (92-97%). LN-Code achieved an area under the curve (AUC) of 0.93 and a sensitivity of 0.88 for identifying LN using the inclusive definition. LN-No Code reached an AUC of 0.91 and a sensitivity of 0.95 (0.97 for the strict definition). Both scoring systems had good external validity, calibration and performance across racial and ethnic groups.Conclusions This study quantified the underutilisation of LN diagnosis codes in EHRs and introduced two adaptable scoring systems to enhance LN identification. Further validation in diverse healthcare settings is essential to ensure their broader applicability.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] USING INTEGRATED ELECTRONIC HEALTH RECORD DATA TO IDENTIFY PATIENTS WITH ADVANCED HEART FAILURE PROFILES
    Martyn, Trejeeve
    Saef, Joshua
    West, Lucianne
    Block-Beach, Hunter
    Brophy, Todd
    Hohman, Jessica
    Starling, Randall C.
    Tang, Wai Hong Wilson
    Khot, Umesh
    Estep, Jerry D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 455 - 455
  • [42] Validation of electronic health record data to identify hospital-associated Clostridioides difficile infections for retrospective research
    Ray, Michael J.
    Lacanilao, Kathleen L.
    Lazaro, Maela Robyne
    Strnad, Luke C.
    Furuno, Jon P.
    Royster, Kelly
    McGregor, Jessina C.
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2024,
  • [43] Application of an Electronic Frailty Index to Identify High-Risk Older Adults Using Electronic Health Record Data
    Kochar, Bharati
    Cheng, David
    Lehto, Hanna-Riikka
    Jain, Nelia
    Araka, Elizabeth
    Ritchie, Christine S.
    Bernacki, Rachelle
    Orkaby, Ariela R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2025,
  • [44] Natural language processing and machine learning to identify alcohol misuse from the electronic health record in trauma patients: development and internal validation
    Afshar, Majid
    Phillips, Andrew
    Karnik, Niranjan
    Mueller, Jeanne
    To, Daniel
    Gonzalez, Richard
    Price, Ron
    Cooper, Richard
    Joyce, Cara
    Dligach, Dmitriy
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2019, 26 (03) : 254 - 261
  • [45] DEVELOPMENT AND VALIDATION OF A STENT THROMBOSIS RISK SCORING SYSTEM
    Malik, Nikesh
    Banning, Amerjeet
    Gershlick, Anthony
    HEART, 2014, 100 : A39 - A40
  • [46] Development and Validation of Algorithms to Identify Cutaneous Lupus Patients Using Diagnostic Codes and Prescription Data
    Guo, Lisa
    Said, Jordan
    Nambudiri, Vinod
    Merola, Joseph
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 619 - 621
  • [47] Development and evaluation of a computable phenotype to identify pediatric patients with leukemia and lymphoma treated with chemotherapy using electronic health record data
    Phillips, Charles A.
    Razzaghi, Hanieh
    Aglio, Taylor
    McNeil, Michael J.
    Salvesen-Quinn, Mikaela
    Sopfe, Jenna
    Wilkes, Jennifer J.
    Forrest, Christopher B.
    Bailey, L. Charles
    PEDIATRIC BLOOD & CANCER, 2019, 66 (09)
  • [48] The Development and Validation of a Machine Learning Model to Predict Bacteremia and Fungemia in Hospitalized Patients Using Electronic Health Record Data
    Bhavani, Sivasubramanium V.
    Lonjers, Zachary
    Carey, Kyle A.
    Afshar, Majid
    Gilbert, Emily R.
    Shah, Nirav S.
    Huang, Elbert S.
    Churpek, Matthew M.
    CRITICAL CARE MEDICINE, 2020, 48 (11) : E1020 - E1028
  • [49] Identifying transient ischemic attack (TIA) patients at high-risk of adverse outcomes: development and validation of an approach using electronic health record data
    Myers, Laura J.
    Perkins, Anthony J.
    Zhang, Ying
    Bravata, Dawn M.
    BMC NEUROLOGY, 2022, 22 (01)
  • [50] Identifying transient ischemic attack (TIA) patients at high-risk of adverse outcomes: development and validation of an approach using electronic health record data
    Laura J. Myers
    Anthony J. Perkins
    Ying Zhang
    Dawn M. Bravata
    BMC Neurology, 22